Cargando…

Past, present, and future of pharmacovigilance in Korea

As an essential part of patient safety, pharmacovigilance is of worldwide interest and should expand its scope and focus on new emerging issues. South Korea has been making continuous efforts in the field of pharmacovigilance for the last 3 decades since voluntary adverse drug reaction (ADR) reporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dong Yoon, Ahn, Kyung-Min, Kang, Hye-Ryun, Cho, Sang-Heon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537083/
https://www.ncbi.nlm.nih.gov/pubmed/28765823
http://dx.doi.org/10.5415/apallergy.2017.7.3.173
_version_ 1783254104048402432
author Kang, Dong Yoon
Ahn, Kyung-Min
Kang, Hye-Ryun
Cho, Sang-Heon
author_facet Kang, Dong Yoon
Ahn, Kyung-Min
Kang, Hye-Ryun
Cho, Sang-Heon
author_sort Kang, Dong Yoon
collection PubMed
description As an essential part of patient safety, pharmacovigilance is of worldwide interest and should expand its scope and focus on new emerging issues. South Korea has been making continuous efforts in the field of pharmacovigilance for the last 3 decades since voluntary adverse drug reaction (ADR) reporting system was first launched in 1988. Korea joined the World Health Organization Program for International Drug Monitoring in 1992, and the activities of Pharmacovigilance Research Network, Korean Society for Pharmacoepidemiology and Risk Management, and Regional Pharmacovigilance Center (RPVC) have contributed to the remarkable progress in the pharmacovigilance area and global status. RPVCs have played pivotal roles in establishment of pharmacovigilance system in Korea by monitoring voluntary ADR reports. RPVCs started with 3 hospitals in 2006 and have now expanded to 27 hospitals nationwide. The Korea Institute of Drug Safety & Risk Management was established in 2012 and in charge of operating the decentralized national pharmacovigilance system. The voluntary report of ADR, which is the basis of current pharmacovigilance system, has various limitations and an active surveillance system can be the overarching alternative. This change in pharmacovigilance paradigm is a global trend and Korea has excellent infrastructure such as broad distribution of electronic medical recording systems and a nationwide single healthcare insurance. As a result, the pharmacovigilance in Korea is now expected to progress to a new active surveillance system from traditional spontaneous reporting system.
format Online
Article
Text
id pubmed-5537083
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-55370832017-08-01 Past, present, and future of pharmacovigilance in Korea Kang, Dong Yoon Ahn, Kyung-Min Kang, Hye-Ryun Cho, Sang-Heon Asia Pac Allergy Educational & Teaching Material As an essential part of patient safety, pharmacovigilance is of worldwide interest and should expand its scope and focus on new emerging issues. South Korea has been making continuous efforts in the field of pharmacovigilance for the last 3 decades since voluntary adverse drug reaction (ADR) reporting system was first launched in 1988. Korea joined the World Health Organization Program for International Drug Monitoring in 1992, and the activities of Pharmacovigilance Research Network, Korean Society for Pharmacoepidemiology and Risk Management, and Regional Pharmacovigilance Center (RPVC) have contributed to the remarkable progress in the pharmacovigilance area and global status. RPVCs have played pivotal roles in establishment of pharmacovigilance system in Korea by monitoring voluntary ADR reports. RPVCs started with 3 hospitals in 2006 and have now expanded to 27 hospitals nationwide. The Korea Institute of Drug Safety & Risk Management was established in 2012 and in charge of operating the decentralized national pharmacovigilance system. The voluntary report of ADR, which is the basis of current pharmacovigilance system, has various limitations and an active surveillance system can be the overarching alternative. This change in pharmacovigilance paradigm is a global trend and Korea has excellent infrastructure such as broad distribution of electronic medical recording systems and a nationwide single healthcare insurance. As a result, the pharmacovigilance in Korea is now expected to progress to a new active surveillance system from traditional spontaneous reporting system. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2017-07 2017-07-19 /pmc/articles/PMC5537083/ /pubmed/28765823 http://dx.doi.org/10.5415/apallergy.2017.7.3.173 Text en Copyright © 2017. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Educational & Teaching Material
Kang, Dong Yoon
Ahn, Kyung-Min
Kang, Hye-Ryun
Cho, Sang-Heon
Past, present, and future of pharmacovigilance in Korea
title Past, present, and future of pharmacovigilance in Korea
title_full Past, present, and future of pharmacovigilance in Korea
title_fullStr Past, present, and future of pharmacovigilance in Korea
title_full_unstemmed Past, present, and future of pharmacovigilance in Korea
title_short Past, present, and future of pharmacovigilance in Korea
title_sort past, present, and future of pharmacovigilance in korea
topic Educational & Teaching Material
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537083/
https://www.ncbi.nlm.nih.gov/pubmed/28765823
http://dx.doi.org/10.5415/apallergy.2017.7.3.173
work_keys_str_mv AT kangdongyoon pastpresentandfutureofpharmacovigilanceinkorea
AT ahnkyungmin pastpresentandfutureofpharmacovigilanceinkorea
AT kanghyeryun pastpresentandfutureofpharmacovigilanceinkorea
AT chosangheon pastpresentandfutureofpharmacovigilanceinkorea